4 hours How Much Upside is Left in Amicus Therapeutics (FOLD)? Wall Street Analysts Think 43.44%Zacks
The consensus price target hints at a 43.4% upside potential for Amicus Therapeutics (FOLD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
X